WISP1 can induce fibroblast proliferation and ECM deposition in the pathological remodelling of asthma [12], and its concentration increases in patients with idiopathic PF and in lung fibrosis animal models [13, 14]. This evidence concerns the gene CCN4 and pulmonary fibrosis.